Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	581.23M -29.7%
Revenue (ttm)	165.60M -6.1%
Net Income	43.47M -20.6%
EPS	0.05 -20.6%
Shares Out	n/a
PE Ratio	13.37
Forward PE	11.73
Dividend	0.04 (6.61%)
Ex-Dividend Date	Jun 12, 2026

Volume	n/a
Open	0.6700
Previous Close	0.6800
Day's Range	0.6700 - 0.6700
52-Week Range	0.6700 - 1.0500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1669
• Employees: 780
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2025, FRA:TQR's revenue was 1.51 billion, a decrease of -6.10% compared to the previous year's 1.61 billion. Earnings were 397.22 million, a decrease of -20.60%.

Financial numbers in HKD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error